Policy 1.02 — Interpreting Physician Continuing Qualifications

MAMMOLOGIX

EXECUTIVE SUMMARY | Policy 1.02 — Interpreting Physician Continuing Qualifications

Protecting Mammography Quality Through Verified Physician Readiness

Prepared for Facility Leadership, Medical Directors, and Compliance Officers

Mammography quality begins before a report is signed. It depends on whether the physician interpreting the examination remains qualified, experienced, educated, and authorized to perform independent mammography interpretation. Policy 1.02, Interpreting Physician Continuing Qualifications, establishes the facility's operating standard for verifying and maintaining those qualifications before any physician independently interprets mammograms for the facility.

The federal foundation for this policy is not new. In the 1997 MQSA final rule, FDA explained that MQSA was enacted to establish national quality standards for mammography and to correct serious quality concerns that included poorly trained interpreting physicians, lack of consistent oversight, and inconsistent facility quality practices. The same rule identified initial and continuing qualification standards for interpreting physicians, radiologic technologists, medical physicists, and inspectors as a core feature of the MQSA framework.

The 2023 MQSA Final Rule did not erase that foundation. Instead, it modernized the mammography regulations while preserving the central role of qualified personnel. FDA stated that high-quality mammography requires, among other things, interpretation by qualified physicians, and that MQSA establishes uniform baseline federal standards to support access to quality mammography services nationwide. FDA also described the MQSA regulations as covering personnel qualifications, equipment standards, quality assurance, recordkeeping, reporting, communication of results, and clinical image review.

Policy 1.02 translates those federal requirements into a practical facility control: no physician may independently interpret mammograms unless the facility has verified and documented that the physician currently meets MQSA interpreting physician requirements or has properly reestablished qualifications after a lapse. The policy applies equally to employed radiologists, contracted physicians, locum tenens coverage, temporary readers, teleradiology physicians, and physicians returning after a leave of absence or extended interruption.

Under 21 CFR 900.12(a)(1)(ii), an interpreting physician must maintain continuing experience by interpreting or multi-reading at least 960 mammographic examinations during the applicable 24-month period. The facility must choose the permitted measurement date used to define that period: the annual MQSA inspection date, the last day of the calendar quarter preceding the inspection, or a date between those two dates. Policy 1.02 appropriately converts that federal requirement into an auditable process by requiring the facility to document the selected measurement date and apply it consistently.

The same regulation requires continuing education. After the applicable regulatory anniversary, an interpreting physician must have taught or completed at least 15 Category I continuing medical education credits in mammography during the applicable 36-month period. The regulation also requires at least six Category I credits in each mammographic modality used by the interpreting physician, and it requires at least eight hours of training before the physician independently interprets mammograms produced by a new mammographic modality.

The policy's strongest operational feature is its treatment of missing or failed qualifications as a scheduling stop, not merely a credentialing concern. If experience or education cannot be verified, independent interpretation should not proceed. If the physician fails the continuing experience requirement, federal regulation requires reestablishment before independent interpretation resumes. The physician must either interpret or multi-read at least 240 mammographic examinations under direct supervision or interpret enough supervised examinations to bring the prior 24-month total to 960, whichever is less. Those supervised interpretations must occur within the six months immediately before resuming independent interpretation.

For a continuing education lapse, the federal requirement is different: the physician must obtain enough additional Category I mammography CME to bring the total to the required 15 credits in the previous 36 months before resuming independent interpretation. CME does not substitute for supervised experience, and supervised experience does not substitute for CME. Policy 1.02 correctly separates these pathways and requires written authorization before independent interpretation resumes.

The policy also recognizes a common operational risk: a physician may be clinically capable but administratively unverifiable. MQSA requires facilities to maintain records of training and experience relevant to personnel qualifications for interpreting physicians, radiologic technologists, and medical physicists, and those records must be available for MQSA inspection. Records for personnel no longer employed by the facility must be maintained for at least 24 months after departure and remain available for annual inspection during that period.

This matters especially for locum tenens, contracted reading groups, and teleradiology arrangements. A contract or verbal assurance is not the same as inspection-ready documentation. Policy 1.02 appropriately requires current qualification documentation or reliable attestation before first engagement and before re-engagement after a material gap. That approach is consistent with the underlying MQSA structure because the facility remains responsible for ensuring that physicians interpreting mammograms under its service meet applicable personnel requirements.

The policy also correctly avoids an unsafe assumption about leaves of absence or practice interruptions. MQSA measurement windows are not paused or prorated because a physician was away from mammography interpretation. A physician returning after interruption must still be evaluated against the applicable 24-month experience and 36-month education periods. If current qualification cannot be verified, the physician should not resume independent interpretation until the appropriate reestablishment pathway is complete.

From a governance standpoint, Policy 1.02 assigns accountability where it belongs. The Lead Interpreting Physician is responsible for the mammography quality assurance program, and the eCFR defines that role as the interpreting physician assigned general responsibility for ensuring that the facility's quality assurance program meets the requirements of 21 CFR 900.12(d) through (f). The regulation also requires the facility to identify a Lead Interpreting Physician and limits assignment of QA tasks to individuals whose qualifications and performance have been determined adequate.

The 1999 Federal Register amendment is useful context but not the primary authority for this policy. That rule addressed a conflict between MQSA mammography regulations and electronic product radiation control performance standards involving x-ray field alignment and image receptor requirements. It confirms the broader point that MQSA rules have evolved through Federal Register actions, but it does not materially change the interpreting physician continuing qualification requirements that drive Policy 1.02.

Executive Takeaway

Policy 1.02 is a patient-safety, quality-assurance, and inspection-readiness policy. Its central purpose is to prevent a facility from relying on assumption, reputation, contract language, or historical qualification when current MQSA qualification has not been verified.

A well-run mammography program should be able to answer four questions at any time:

• Which physicians are authorized to independently interpret mammograms for this facility?
• Does each physician meet the current 24-month experience and 36-month CME requirements?
• Is modality-specific training documented before the physician interprets that modality?
• If there was a lapse, is the correct reestablishment pathway completed and signed before independent interpretation resumes?

Policy 1.02 provides the structure for those answers. It turns federal MQSA standards into a working facility process: verify qualifications, document the evidence, monitor before a lapse occurs, stop independent interpretation when qualification is missing or deficient, and reauthorize only after the federal pathway has been satisfied.